Withdrawal of antidepressants does not impact the efficacy of COMP360 psilocybin therapy: results from a phase IIb randomised controlled trial
Guy M. Goodwin, Megan Croal, J. Chai-Rees, Lindsey Marwood, S. Mistry, Anna Nowakowska, H. Clifton Simmons, Jeng‐yu Tsai
Neuroscience Applied January 1, 2023 DOI: 10.1016/j.nsa.2023.103487 (opens in new tab) via OpenAlex
Study at a glance
| Characteristics | Randomized Peer reviewed |
|---|---|
| Topics | Psilocybin |
| Keywords | Internal medicine Psychiatry Hallucinogen |
Abstract
No abstract available from the source.